ClinicalTrials.Veeva

Menu

A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1

Mayo Clinic logo

Mayo Clinic

Status

Active, not recruiting

Conditions

Pulmonary Embolism

Treatments

Device: Incentive spirometer.
Other: Augmented pulse oximetry using incentive spirometer.

Study type

Interventional

Funder types

Other

Identifiers

NCT01898637
12-009527

Details and patient eligibility

About

The goal of this project is to determine if the change in oxygen saturation during deep inspiration ("augmented pulse oximetry") can be used as a method to rule out pulmonary embolism (PE). The investigators propose to evaluate a simple, non-invasive clinical tool to help rule out PE. The investigators plan to measure the oxygen saturation of 40 consecutive patients with newly-diagnosed PE (within 60 minutes of diagnosis) and 80 matched controls who do not have a PE. Trained, blinded Respiratory Therapists or Study Coordinators will record each patient's oxygen saturation before, during, and after a 2-minute period of deep inspirations (vital capacity [the maximal amount of air that can be inhaled, measured in milliliters]) using an incentive spirometer. The investigators' central hypothesis is that persons with a PE will not respond to augmented pulse oximetry and will not significantly improve or normalize their oxygen saturation.

Full description

Patients will be identified and enrolled by the Mayo Clinic St. Marys Emergency Department staff as they are undergoing medical care in the Emergency Department.

The investigators will calculate the difference in oxygen saturation pre- and post-deep inspiration (ΔSpO2 at 1 minute, 2 minutes and 4 minutes), and then correlate these values with the CT result.

In cases of PE, The investigators expect the SpO2 to remain unchanged, or to change less than 3-5%. The investigators expect alternate hypoxemic conditions to have a significantly greater increase in SpO2.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or greater.
  • Agrees and able to participate in the study.
  • Room air SpO2 (oxygen saturation) less than 92% and newly-diagnosed PE (or controls with no PE) based on CT angiogram result.

Exclusion criteria

  • Clinical concern for instability.
  • Systolic blood pressure less than 100 mm Hg.
  • Heart rate ≥140 beats per minute.
  • Oxygen saturation less than 85% with more than 4 L supplemental oxygen.
  • Unable to participate/comply with instructions for using the incentive spirometer.
  • Patients from the Federal Medical Center in Rochester, Minnesota.
  • Patients who do not speak English (due to the need for expediency).

Patients will be under the care of the Emergency Department team who have the skills and resources to monitor and treat patients if they were to become unstable.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,500 participants in 2 patient groups

Proven pulmonary embolism.
Active Comparator group
Description:
Augmented pulse oximetry using incentive spirometer. Emergency Department patients with pulmonary embolism.
Treatment:
Other: Augmented pulse oximetry using incentive spirometer.
Device: Incentive spirometer.
Control patients
Other group
Description:
Augmented pulse oximetry using incentive spirometer. Emergency Department patients who do not have pulmonary embolism.
Treatment:
Other: Augmented pulse oximetry using incentive spirometer.
Device: Incentive spirometer.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems